Prokar was on the board of Intuitive Surgical as an advisor for many years. This is the world’s leading, multi-billion $ robotics company that has changed the way surgery is practised especially in patients with cancer. As a result robotic assisted radical prostatectomy has grown from a single institution in UK where he pioneered this procedure to >90% of procedures nationally over a 20 year period. He have advised and critically analysed the costs of robotic surgery and especially the societal benefits that it brings worldwide by reducing out of pocket costs.
Prokar has been on the advisory boards of newer robotic companies – Cambridge Medical Robotics, Medtronics, Auris, Surgenius and Google-Johnson & Johnson. This growing market is likely to increase the access to minimally invasive surgery for patient benefit. He is Chief Scientific Officer for Proximie an augmented reality company with the mission of democratising surgery globally, QrATIv, a medical AI company and serve on the advisory board of Jiva.Ai a UK based start-up, improving radiological diagnoses through machine learning.
He served on the advisory boards of Allergan, manufacturers of Botox, the only FDA approved product and led key trials to assist with its licensing process.